Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Vapendavir diphosphate is a potent enteroviral capsid binder (CB) and has a potent antiviral activity for enterovirus 71 (EV71) replication (EC50: 0.5-1.4 μM in different EV71 strains).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 670.00 | |
50 mg | 6-8 weeks | $ 871.00 | |
100 mg | 6-8 weeks | $ 1,470.00 |
Description | Vapendavir diphosphate is a potent enteroviral capsid binder (CB) and has a potent antiviral activity for enterovirus 71 (EV71) replication (EC50: 0.5-1.4 μM in different EV71 strains). |
Targets&IC50 | EV71 strains:(EC50)0.5-1.4 μM |
In vitro | In vitro, Vapendavir efficiently inhibit the replication of 21 EV71 strains/isolates that are representative of the different genogroups A, B, and C[2]. |
Synonyms | BTA798 diphosphate |
Molecular Weight | 578.45 |
Formula | C21H32N4O11P2 |
CAS No. | 1198151-75-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 6.75 mg/mL (11.67 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Vapendavir diphosphate 1198151-75-5 Others BTA798 Diphosphate Vapendavir Diphosphate BTA 798 Diphosphate Vapendavir BTA-798 Diphosphate BTA 798 BTA798 diphosphate BTA-798 BTA798 inhibitor inhibit